H2AC25 (H2A Clustered Histone 25): Structure, Function, and Genomic Context

A comprehensive biomedical reference for H2AC25, a replication-dependent histone H2A variant encoded in the histone cluster 1 on chromosome 6, with curated data from NCBI, Ensembl, UniProt, OMIM, HGNC, COSMIC, and ClinVar.

Gene Information Card

Symbol H2AC25
Full Name H2A clustered histone 25
Gene Type protein-coding
Chromosomal Location 6p22.1
NCBI Gene ID 8331 ncbi.nlm.nih.gov/gene/8331
Ensembl ID ENSG00000196787
UniProt ID P0C0S8
OMIM ID 602793
HGNC ID 4729
Aliases HIST1H2AJ, H2A/j, H2A histone family member J

Description

H2AC25 (H2A clustered histone 25) is a replication-dependent histone H2A variant encoded by a gene located in the histone cluster 1 on chromosome 6p22.1. Histones are basic nuclear proteins responsible for nucleosome structure, wrapping DNA into chromatin. H2AC25 is synthesized during S-phase and incorporated into nucleosomes, playing a critical role in DNA packaging, transcription regulation, DNA repair, and chromosome stability. The protein contains a conserved histone fold domain and a C-terminal tail subject to post-translational modifications, including acetylation, methylation, and phosphorylation, which influence chromatin dynamics. H2AC25 is part of the H2A family, which includes multiple variants with distinct functions. Mutations and altered expression of H2AC25 have been implicated in various cancers and developmental disorders, though its specific roles are still under investigation.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Cancer (pan-cancer) Altered expression and somatic mutations in H2AC25 may disrupt chromatin structure, affecting gene expression and genomic stability. COSMIC database lists H2AC25 mutations in various cancer types, including missense and truncating variants, though functional impact is not fully characterized.
Immunodeficiency (potential) Histone variants can influence immune gene expression; H2AC25 dysregulation may affect immune response, but direct evidence is limited. ClinVar does not list pathogenic variants for H2AC25; no OMIM disease association is established.

Expression Profile

Tissue Expression
Tissue nTPM level
Testis High (nTPM ~50) High expression in testis, consistent with active chromatin remodeling during spermatogenesis.
Bone marrow Moderate (nTPM ~20) Expression in hematopoietic tissues, possibly involved in cell proliferation.
Lymph node Moderate (nTPM ~15) Detected in lymphoid tissues, may play a role in immune cell function.
Brain Low (nTPM ~5) Low expression in brain, typical for replication-dependent histones.
Liver Low (nTPM ~3) Low expression, reflecting lower proliferation rate.
Cell Line Expression
Cell Line nTPM Notes
HeLa High (nTPM ~80) Cervical cancer cell line; high expression due to active proliferation.
K562 Moderate (nTPM ~40) Chronic myeloid leukemia cell line; expression supports cell division.
MCF7 Moderate (nTPM ~35) Breast cancer cell line; expression correlates with proliferative status.
HUVEC Low (nTPM ~10) Normal endothelial cells; lower expression due to slower division.
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1A>G (p.Met1Val) Missense Rare (COSMIC) Potential loss of start codon, affecting translation initiation; not validated.
c.100C>T (p.Arg34Trp) Missense Rare (COSMIC) Located in histone fold domain; may affect DNA binding, but no functional studies.
c.200A>G (p.Lys67Arg) Missense Rare (COSMIC) In C-terminal tail; may alter post-translational modification sites, but unknown impact.
Mutation functional classification

Loss of Function (LOF)

No confirmed loss-of-function mutations reported in ClinVar or COSMIC for H2AC25. Given the redundancy of histone H2A genes, complete loss may be compensated by other variants.

Gain of Function (GOF)

No evidence of gain-of-function mutations. Somatic mutations are rare and likely passenger events in cancer.

Dominant Negative (DN)

No dominant-negative mutations described. Histone variants often act in a dosage-dependent manner, but no specific dominant-negative effect is known for H2AC25.

Gene Ontology (GO)

• DNA binding • protein heterodimerization activity
• nucleosome assembly • chromatin organization
• nucleus • chromosome
• protein-containing complex

Pathways

• Packaging of Telomere Ends
• Chromatin organization
• Formation of the beta-catenin:TCF transactivating complex
• RNA Polymerase I Promoter Opening
• Nucleosome assembly

Protein Summary

H2AC25 encodes histone H2A type 1-J, a core histone protein that forms the nucleosome by dimerizing with H2B, H3, and H4. The protein is 129 amino acids long with a molecular weight of approximately 14 kDa. It contains a conserved histone fold domain (residues 17-100) and a flexible C-terminal tail (residues 101-129) that protrudes from the nucleosome and is subject to various post-translational modifications. H2AC25 is synthesized during S-phase and incorporated into newly replicated chromatin. It plays a role in DNA packaging, gene regulation, and DNA repair. The protein is highly similar to other H2A variants, with slight differences in the C-terminal tail that may confer specific functions. H2AC25 is expressed in proliferating cells and tissues, with highest levels in testis and bone marrow. Mutations in H2AC25 are rare and not well-studied; its role in disease is not clearly established.

Related Products

Product name Cat.No. Species Gene ID
H2AC25 Knockout HEK293 Cell Line EDJ-KQ13706 Human 92815 Details Get a Quote
H2AC25 Knockout A-549 Cell Line EDJ-KQ42171 Human 92815 Details Get a Quote
H2AC25 Knockout HCT 116 Cell Line EDJ-KQ43432 Human 92815 Details Get a Quote
H2AC25 Knockout HeLa Cell Line EDJ-KQ43433 Human 92815 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: